Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age

doi:10.1016/0022-510X(85)90129-7

Journal of the Neurological Sciences

Volume 69, Issue 3, July 1985, Pages 139-159

https://doi.org/10.1016/0022-510X(85)90129-7 Get rights and content

Abstract

The frequency of senile plaques and neurofibrillary tangles and the number of pyramidal neurones and the volume of their nucleolus were measured in temporal cortex (middle temporal gyrus) and hippocampus (area h₁) of 32 patients with Alzheimer's disease. Plaques and tangles were greatly increased in frequency in these patients while the pyramidal cell number was reduced (due to the effects of ageing plus disease) by a total of 78% in temporal cortex and 60% in hippocampus with nucleolar volume in surviving cells being reduced in total by 56% and 63%, respectively. These total losses did not correlate with patient age. However, when corrections for the effects of ageing alone were made on these total losses, the extent of pyramidal cell loss and decrease in nucleolar volume due solely to disease as well as the frequency of plaques and tangles were all found to correlate inversely with patient age for temporal cortex; in hippocampus only cell loss so related. The extent of nerve cell loss correlated with the reduction in nucleolar volume in temporal cortex but not in hippocampus. Correlations involving nerve cell loss and decreased nucleolar volume with plaque and tangle frequency were either weak or non-significant in both regions. The number of nerve cells and the volume of their nucleolus were less (when compared with age-matched control patients) in both temporal cortex and hippocampus, in the 6 middle aged patients with Down's syndrome, and match the corresponding values seen in 8 patients of similar age with Alzheimer's disease.

References (40)

J.M. Candy et al.
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases
J. Neurol. Sci.
(1983)
G. Henderson et al.
Cell counts in the human cerebral cortex in normal adults throughout life using an image analysing computer
J. Neurol. Sci.
(1980)
B.M. Hubbard et al.
A quantitative study of cerebral atrophy in old age and senile dementia
J. Neurol. Sci.
(1981)
L.L. Iversen et al.
Loss of pigmented dopamine-β-hydroxylase positive cells from locus caeruleus in senile dementia of Alzheimer's type
Neurosci. Lett.
(1983)
C.Q. Mountjoy et al.
Cortical neuronal counts in normal elderly controls and demented patients
Neurobiol. Ageing
(1983)
F. Tagliavini et al.
Basal nucleus of Meynert — A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea
J. Neurol. Sci.
(1983)
B.E. Tomlinson et al.
Observations on the brains of non demented old people
J. Neurol. Sci.
(1968)
B.E. Tomlinson et al.
Observations on the brains of demented old people
J. Neurol. Sci.
(1970)
B.E. Tomlinson et al.
Cell loss in the locus caeruleus in senile dementia of Alzheimer type
J. Neurol. Sci.
(1981)
G.K. Wilcock et al.
Plaques, tangles and dementia — A quantitative study
J. Neurol. Sci.
(1982)

W.A. Aherne et al.

The estimation of neuronal population density by a robust distance method

J. Microsc.

(1978)

J.M. Anderson et al.

The effect of advanced old age on the neurone content of the cerebral cortex

J. Neurol. Sci.

(1983)

M.J. Ball

Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

Acta Neuropath. (Berl.)

(1977)

M.J. Ball

Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of ageing and demented patients — A quantitative study

Acta Neuropath. (Berl.)

(1978)

M.J. Ball et al.

Neurofibrillary tangles, granulovacuolar degeneration and neuron loss in Down's syndrome — Quantitative comparison with Alzheimer dementia

Ann. Neurol.

(1980)

G. Blessed et al.

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects

Brit. J. Psychiat.

(1968)

W. Bondareff et al.

Loss of neurones of adrenergic projection to cerebral cortex (nucleus locus caeruleus) in senile dementia

Neurology

(1982)

H. Brody

Organization of the cerebral cortex, Part 3 (A study of ageing in the human cerebral cortex)

Comp. Neurol.

(1955)

H. Brody

Structural changes in the human nervous system

Interdisciplinary Top. Gerontol.

(1970)

A. Brun et al.

Regional pattern of degeneration in Alzheimer's disease — Neuronal loss and histopathological grading

Histopathology

(1981)

Cited by (200)

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
2018, Alzheimer's and Dementia
Citation Excerpt :
The reason for this is manifold, including that clinical symptoms often are vague or uncharacteristic, and overlap with those seen in other neurodegenerative disorders. In addition, the severity of plaques and tangles load overlaps with that found in cognitively unimpaired older adult patients [17,22]. Moreover, a substantial proportion of older adult patients with clinical AD has multiple pathologies, with variable severities of other proteinopathies (TDP-43 and α-synuclein), as well as cerebrovascular disease, except for plaques and tangles [27,28].
The Alzheimer's Association convened a multidisciplinary workgroup to develop appropriate use criteria to guide the safe and optimal use of the lumbar puncture procedure and cerebrospinal fluid (CSF) testing for Alzheimer's disease pathology detection in the diagnostic process.
The workgroup, experienced in the ethical use of lumbar puncture and CSF analysis, developed key research questions to guide the systematic review of the evidence and developed clinical indications commonly encountered in clinical practice based on key patient groups in whom the use of lumbar puncture and CSF may be considered as part of the diagnostic process. Based on their expertise and interpretation of the evidence from systematic review, members rated each indication as appropriate or inappropriate.
The workgroup finalized 14 indications, rating 6 appropriate and 8 inappropriate.
In anticipation of the emergence of more reliable CSF analysis platforms, the manuscript offers important guidance to health-care practitioners and suggestions for implementation and future research.
Vitamins associated with brain aging, mild cognitive impairment, and alzheimer disease: Biomarkers, epidemiological and experimental evidence, plausible mechanisms, and knowledge gaps
2017, Advances in Nutrition
The key to preventing brain aging, mild cognitive impairment (MCI), and Alzheimer disease (AD) via vitamin intake is first to understand molecular mechanisms, then to deduce relevant biomarkers, and subsequently to test the level of evidence for the impact of vitamins in the relevant pathways and their modulation of dementia risk. This narrative review infers information on mechanisms from gene and metabolic defects associated with MCI and AD, and assesses the role of vitamins using recent results from animal and human studies. Current evidence suggests that all known vitamins and some “quasi-vitamins” are involved as cofactors or influence ≥1 of the 6 key sets of pathways or pathologies associated with MCI or AD, relating to 1) 1-carbon metabolism, 2) DNA damage and repair, 3) mitochondrial function and glucose metabolism, 4) lipid and phospholipid metabolism and myelination, 5) neurotransmitter synthesis and synaptogenesis, and 6) amyloidosis and Tau protein phosphorylation. The contemporary level of evidence for each of the vitamins varies considerably, but it is notable that B vitamins are involved as cofactors in all of the core pathways or pathologies and, together with vitamins C and E, are consistently associated with a protective role against dementia. Outcomes from recent studies indicate that the efficacy and safety of supplementation with vitamins to prevent MCI and the early stages of AD will most likely depend on 1) which pathways are defective, 2) which vitamins are deficient and could correct the relevant metabolic defects, and 3) the modulating impact of nutrient-nutrient and nutrient-genotype interaction. More focus on a precision nutrition approach is required to realize the full potential of vitamin therapy in preventing dementia and to avoid causing harm.
Increased synchronization and decreased neural complexity underlie thalamocortical oscillatory dynamics in mild cognitive impairment
2009, NeuroImage
Abnormal patterns of electroencephalographic (EEG) alpha oscillations in preclinical stages of dementia reveal a selective vulnerability of thalamocortical circuits to the cascade of neurodegenerative events heralding Alzheimer's disease (AD). EEG-alpha slowing characterizes both mild cognitive impairment (MCI) and healthy aging, but it remains ambiguous whether different neural mechanisms underlie this oscillatory behavior in normal and pathological senescence. In this study, we show that the strength of phase coupling and the level of phase predictability between thalamocortical and cortico-cortical EEG sources of low alpha frequency are abnormally facilitated in MCI patients when compared to healthy elderly subjects. Additionally, we found a loss of neural complexity intrinsic to both thalamic and cortical generators of lower alpha in MCI patients, which likely influenced the aberrant phase synchronization behavior between EEG-alpha sources in this high risk group of AD. Taken together, these results suggest that different neural mechanisms account for the well known slowing of alpha rhythm present in normal aging and MCI patients. Whether these anomalous neural coding mechanisms of lower alpha generation in MCI patients represent a potential electrophysiological marker of mild AD is a topic for future research.
Non-tau based neuronal degeneration in Alzheimer's disease - an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex
2008, Brain Research
Citation Excerpt :
In fact, the amount of neuronal loss in the AD neocortex is a matter of controversy. Generally, neurons, particularly those with a size of over 90 µm2, are lost in the temporal and frontal neocortex of AD patients, as compared to those of non-demented controls (Terry et al., 1981; Mountjoy et al., 1983; Mann et al., 1985), while the severity of neuronal loss in AD compared to normal aging tends to decline with the years (Mountjoy et al., 1983; Hubbard and Anderson, 1985; Mann et al., 1985). A correlation between NFT counts and neuronal loss was repeatedly found in the AD neocortex (Mountjoy et al., 1983; Bondareff et al., 1989; Gomez-Isla et al., 1997).
In Alzheimer's disease (AD), cortical neurons develop neurofibrillary tangles (NFTs) consisting of hyperphosphorylated tau. The neurons eventually die. There are some hints that cortical neurons may also degenerate without the development of cytoskeletal changes. We investigated this possibility by comparing changes in APP staining and neuronal size with respect to the presence or absence of hyperphosphorylated tau. Adjacent sections of the medial temporal neocortex (Brodmann's area 22) of 5 male AD patients aged 60–88 years (Braak V–VI) and 5 age-matched male non-demented control subjects were i) stained with a modified Bielschowsky silver method in order to reveal NFTs and ‘ghost’ tangles, ii) single-stained with anti-APP, and iii) double-labeled with anti-APP and AT8. Anti-APP is directed against the β-amyloid precursor protein and stains virtually all perikarya and proximal neurites of the cortical neurons. AT8 stains pre-tangles, NFTs and extracellular ‘ghost’ tangles due to the recognition of hyperphosphorylated tau. The study was focused on the supragranular cortical layers II–III, since these layers can be clearly delineated from the adjacent molecular and granular cell layers. The results showed that i) APP staining intensity in neurons was variable in the AD cortex, being clearly different from the invariably intense neuronal staining in all controls. Reduced cytoplasmic APP staining was observed, particular in small neurons, while lack of anti-APP staining in proximal neurites, too, was associated with AD. In addition, ii) cross-sectional area measurement on anti-APP-stained neurons revealed that in AD, as compared to controls, a clear decrease in the number of mainly large-sized neurons (> 150 µm²) was accompanied by a significant increase in the percentage of neurons in the smaller size classes, indicating that many large-sized neurons became smaller in AD. iii) Reduced APP staining and decreased neuronal size were not necessarily associated with the presence or absence of hyperphosphorylated tau in these cells. iv) Twenty-six percent of the neurons contained hyperphosphorylated tau, while the level of NFT-related neuronal loss was low in AD. The present study suggests that non-tau based neuronal degeneration is a major phenomenon in the AD neocortex.
Age, neuropathology, and dementia
2009, New England Journal of Medicine
Research in Alzheimer's disease is focused mainly on younger old persons, whereas studies involving very old persons report attenuated relationships between the pathological features of Alzheimer's disease and dementia.
We assessed 456 brains donated to the population-based Medical Research Council Cognitive Function and Ageing Study from persons 69 to 103 years of age at death. We used a standard neuropathological protocol that included measures of the pathological features of Alzheimer's disease, cerebral atrophy, and cerebrovascular disease. Neuropathological variables were dichotomized to represent no burden or a mild burden of pathological lesions as compared with a moderate or severe burden. Logistic regression was used to estimate the effect of age on the relationship between neuropathological features and dementia.
The difference in the prevalence of moderate and severe Alzheimer's-type pathological changes between persons with and those without dementia decreased with increasing age. The association between neocortical neuritic plaques and dementia was strong at 75 years of age (odds ratio, 8.63; 95% confidence interval [CI], 3.81 to 19.60) and reduced at 95 years of age (odds ratio, 2.48; 95% CI, 0.92 to 4.14), and similar attenuations with advancing age were observed in the association between other pathological changes related to Alzheimer's disease and dementia in all brain areas. In contrast, neocortical cerebral atrophy maintained a relationship with age in persons with dementia at both 75 years of age (odds ratio, 5.11; 95% CI, 1.94 to 13.46) and 95 years of age (odds ratio, 6.10; 95% CI, 2.80 to 13.28) and thus distinguished the cohort with dementia from the cohort without dementia.
The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons. Age must be taken into account when assessing the likely effect of interventions against dementia on the population.
In this longitudinal study of cognitive function and aging, which included 456 participants who agreed to post-mortem brain examination and died between 69 and 103 years of age, the relationship between the pathological features of Alzheimer's disease and clinical dementia at the time of death was attenuated in the oldest old persons. For example, the odds ratio for the association between dementia and neocortical neuritic plaques was 8.6 at 75 years of age but only 2.5 at 95 years of age.
In this study of cognitive function and aging, the relationship between the postmortem pathological features of Alzheimer's disease and clinical dementia at the time of death was attenuated in the oldest old persons. For example, the odds ratio for the association between dementia and neocortical neuritic plaques was 8.6 at 75 years of age but only 2.5 at 95 years of age.
During the 20th century, interest in the dementias focused on specific disorders defined by criteria that were developed for patients who had onset of dementia before the age of 65 years, which had come to be considered by many as pathologically distinct from late-onset dementia.¹ In the second half of that century, the distinction between early-onset and late-onset dementias was challenged by the realization that the hallmarks of Alzheimer's disease in older persons were indistinguishable from those in younger persons with Alzheimer's disease.² Population epidemiologic studies of dementia have revealed a relentless rise in the incidence of dementia into old . . .
Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults
2023, Alzheimer's and Dementia

View all citing articles on Scopus

^☆: This work was supported in part by a grant to one of us (B.M.) from the North Western Regional Health Authority.

View full text

Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age☆

Abstract

J. Neurol. Sci.

J. Neurol. Sci.

J. Neurol. Sci.

Neurosci. Lett.

Neurobiol. Ageing

J. Neurol. Sci.

J. Neurol. Sci.

J. Neurol. Sci.

J. Neurol. Sci.

J. Neurol. Sci.

The estimation of neuronal population density by a robust distance method

J. Microsc.

The effect of advanced old age on the neurone content of the cerebral cortex

J. Neurol. Sci.

Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

Acta Neuropath. (Berl.)

Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of ageing and demented patients — A quantitative study

Acta Neuropath. (Berl.)

Neurofibrillary tangles, granulovacuolar degeneration and neuron loss in Down's syndrome — Quantitative comparison with Alzheimer dementia

Ann. Neurol.

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects

Brit. J. Psychiat.

Loss of neurones of adrenergic projection to cerebral cortex (nucleus locus caeruleus) in senile dementia

Neurology

Organization of the cerebral cortex, Part 3 (A study of ageing in the human cerebral cortex)

Comp. Neurol.

Structural changes in the human nervous system

Interdisciplinary Top. Gerontol.

Regional pattern of degeneration in Alzheimer's disease — Neuronal loss and histopathological grading

Histopathology